Return to Biostatistics Ethics Case Studies

(PLEASE NOTE: On the bottom of this page, you will find the case study we are discussing and the name of the contributor.)

TITLE Case Study: Should statisticians patent?


BiostatEthicsCaseStudyForm edit

Title_Biostatistics_Ethics_Case_Study Should statisticians patent?
Name_Case_Contributor Shelley Hurwitz
Deidentified_Material Yes
No_Copyright_Restrictions Yes
Case_Presentation Statistical methods and study designs can be patented. Dr. David
A. Schoenfeld, Harvard Medical School, developed a new clinical trial
design, the "Sequential Parallel Design," and considered patenting
it. He asked, is patenting a statistical design ethical? Do you
think patenting methods will impede or encourage their use? Should
patenting be encouraged or discouraged? What are the practical and
ethical consequences of patenting and/or using patented methods?
(posted with permission)
See Also
Disclaimer The views expressed within CTSpedia are those of the author and must not be taken to represent policy or guidance on the behalf of any organization or institution with which the author is affiliated.
This topic: CTSpedia > WebHome > EthicsBiostat > StatEthicsCaseStudies > BiostatEthicsCaseStudy004
Topic revision: 07 Feb 2013, MaryBanach
This site is powered by FoswikiCopyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Foswiki? Send feedback